Calyx and Invicro Rebrand, Unveil New Name and Logo

Calyx and Invicro have officially launched under an all-new corporate identity, namely, “Perceptive”.

The two firms, which specialise in providing medical imaging and development services to the biopharmaceutical industry, merged earlier this year following Calyx’s acquisition of Invicro from REALM IDx.

With a collective history of over 50 years, the duo claim to have been involved in the support of nearly 12,000 clinical research trials and over 800 approvals, spanning all clinical phases and therapeutic fields, with a strong focus on oncology and neuroscience.

“Moving forward under its new name, Perceptive will continue to serve science by delivering clarity and consistency for clinical trials worldwide on delivery, speed, and results,” says the British company.

“We’re honoured to be part of the global healthcare solution by providing unmatched scientific and technological expertise, global operational experience, and end-to-end solutions that ensure confident R&D decision-making,” adds Perceptive CEO, David Herron.

Source: Perceptive